• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 6
      Dr. Harris discusses variation in on-call patterns among urologists - 12 month(s) ago

      “We also saw differences in the average pay per weekday of hospital call; 32% of men reporting receiving over $500 per day [of] week[end] hospital call, but only 18% of women reporting the same,” says Andrew M. Harris, MD.

      Source: www.urologytimes.com
      Categories: General Medicine News, Urology
      Tweet Tweets with this article
      • Profile photo of 	UrologyTimes
        UrologyTimes

        Dr. Andrew Harris discusses variation in on-call patterns among urologists. @AndrewHarris_MD @UKYurology #urology #urologist https://t.co/323Tt7zT9L

    • Mashup Score: 0
      How Northwestern Medicine’s new urology structure will help improve care - 12 month(s) ago

      “We aim to provide the best quality care we can at the locations closest to our patients,” says Edward M. Schaeffer, MD, PhD.

      Source: www.urologytimes.com
      Categories: General Medicine News, Urology
      Tweet Tweets with this article
      • Profile photo of 	UrologyTimes
        UrologyTimes

        Dr. @EdwardSchaeffer discusses how Northwestern Medicine’s new urology structure will help improve care. @NM_Urology #urology #urologist https://t.co/sxFi29QXJ0

    • Mashup Score: 0
      Clinical trials of UroActive System receive support from Series C Financing - 12 month(s) ago

      The UroActive System is currently under investigation in 2 first-in-human clinical trials in male and female patients with SUI.

      Source: www.urologytimes.com
      Categories: General Medicine News, Urology
      Tweet Tweets with this article
      • Profile photo of 	UrologyTimes
        UrologyTimes

        UroMems has raised $47 million in Series C financing to aid large-scale US and European clinical trials of the UroActive System, a smart automated artificial urinary sphincter for patients with stress urinary incontinence. #urology #urologist https://t.co/mUwucfALix

    • Mashup Score: 2
      Subcutaneous nivolumab under review in EU for solid tumor indications - 1 year(s) ago

      Subcutaneous nivolumab is also under review in the United States based on findings from the phase 3 CheckMate-67T trial.

      Source: www.urologytimes.com
      Categories: General Medicine News, Urology
      Tweet Tweets with this article
      • Profile photo of 	UrologyTimes
        UrologyTimes

        The European Medicines Agency has validated an extension application for subcutaneous nivolumab across previously approved indications of nivolumab in solid tumors. #urology #urologist https://t.co/PTTB2E9cQA

    • Mashup Score: 9
      Dr. Das on his experience with HoLEP for treating BPH - 1 year(s) ago

      Urology Times is the leading resource for urologists & allied health professionals offering clinical analysis, policy perspectives, & practical advice.

      Source: www.urologytimes.com
      Categories: General Medicine News, Urology
      Tweet Tweets with this article
      • Profile photo of 	UrologyTimes
        UrologyTimes

        Dr. Akhil Das shares his experience with HoLEP for BPH. @UCI_Urology #urology #urologist https://t.co/gHv1SDWN6j

    • Mashup Score: 1
      Next steps for improving patient knowledge of urinary tract infections - 1 year(s) ago

      “I think these findings are critical in helping us craft educational resources that would be easily understood and easily disseminated by trusted health care providers,” says Stephanie Gleicher, MD, MPH.

      Source: www.urologytimes.com
      Categories: General Medicine News, Urology
      Tweet Tweets with this article
      • Profile photo of 	UrologyTimes
        UrologyTimes

        Dr. Stephanie Gleicher discusses next steps for improving patient knowledge of urinary tract infections. @sgleicher @SmithInstUro #urology #urologist https://t.co/4RcSBqlFME

    • Mashup Score: 0
      D-mannose found to be ineffective for prevention of recurrent UTI - 1 year(s) ago

      “This study reinforces our role as physicians to guide patients away from costly supplements with little or no benefit,” said Wai Lee, MD.

      Source: www.urologytimes.com
      Categories: General Medicine News, Urology
      Tweet Tweets with this article
      • Profile photo of 	UrologyTimes
        UrologyTimes

        Recently published findings show that taking daily D-mannose did not reduce the incidence of recurrent UTIs in women compared with placebo. #urology #urologist https://t.co/OLjhHamzLN

    • Mashup Score: 1
      Digital therapeutics: A potential new care pathway for patients with OAB - 1 year(s) ago

      “I think digital therapeutics and virtual care are going to expand access,” says David Sheyn, MD.

      Source: www.urologytimes.com
      Categories: General Medicine News, Urology
      Tweet Tweets with this article
      • Profile photo of 	UrologyTimes
        UrologyTimes

        "I think digital therapeutics and virtual care are going to expand access," says Dr. David Sheyn. @CaseUrology #urology #urologist https://t.co/obxgvJoVQg

    • Mashup Score: 5
      Dr. Ghoniem on detrusor nerve radiofrequency ablation research - 1 year(s) ago

      “I think having success with that in humans will make [radiofrequency ablation] very, very valuable for the practicing urologist that can be done in the clinic without much training or anything like that,” says Gamal M. Ghoniem, MD, FACS, ABU/FPMRS.

      Source: www.urologytimes.com
      Categories: General Medicine News, Urology
      Tweet Tweets with this article
      • Profile photo of 	UrologyTimes
        UrologyTimes

        Dr. Gamal M. Ghoniem discusses a preclinical study of detrusor nerve radiofrequency ablation for OAB. @ghoniem_gamal @UCI_Urology #urology #urologist https://t.co/I347Ck4Jse

    • Mashup Score: 3
      Aquablation granted new category I CPT code for BPH management - 1 year(s) ago

      The new Category I code will become effective on January 1, 2026.

      Source: www.urologytimes.com
      Categories: General Medicine News, Urology
      Tweet Tweets with this article
      • Profile photo of 	UrologyTimes
        UrologyTimes

        The AMA has granted a Category I CPT code to Aquablation for BPH, replacing the therapy’s existing Category III CPT code. #urology #urologist https://t.co/v1Q1YQlifY

    Load More
    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings